Algenesis
2 known investors
Algenesis develops plant-based, biodegradable polyurethanes intended to replace petroleum-based materials across manufacturing applications. The company offers two chemical systems positioned as durable, non-toxic alternatives that avoid microplastics and support material circularity.
Investors · 2
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Department of Energy | Phase II | 2023 | $1.1M |
| Department of Energy | Phase I | 2022 | $200K |
| Department of Energy | Phase II | 2020 | $1.1M |
| National Science Foundation | Phase II | 2019 | $748.5K |
| Department of Energy | Phase I | 2019 | $199.9K |
| National Science Foundation | Phase I | 2018 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Algenesis do?
- Algenesis develops plant-based, biodegradable polyurethanes intended to replace petroleum-based materials across manufacturing applications. The company offers two chemical systems positioned as durable, non-toxic alternatives that avoid microplastics and support material circularity.
- Who are Algenesis's investors?
- Algenesis's investors include Band of Angels, Swan Venture Fund.